European Archives - Page 137 of 1111 - European Medical Journal

17 Dec 2024

Tralokinumab in the Era of Disruption in Atopic Dermatitis

Gain valuable insights from three atopic dermatitis (AD) specialists who specifically consider one of the newest systemic therapies that targets the cytokine IL-13, a key cytokine involved in the pathogenesis of AD.

Groundbreaking Implant for Real-Time Protein Monitoring

Scientists create a revolutionary implantable device capable of monitoring protein levels in the body in real time.

Acute Form of Sarcoidosis

Sarcoidosis is a disorder that affects multiple systems with unclear causes and is relatively rare. The defining characteristic of this…

Flying with Food Allergies: A Unique Challenge

A global survey highlights the challenges faced by individuals with food allergies during air travel.

Neoadjuvant I-O for Resectable NSCLC

A Breakthrough for NAFLD and Type 2 Diabetes Management

Recent studies have highlighted the potential of sodium-glucose cotransporter 2 inhibitors, especially ertugliflozin, in improving outcomes for patients with NAFLD and T2DM.

3D Echocardiography with Vena Contracta Area Predicts Survival After Mitral TEER

3D-Vena Contracta Area (VCA) predicts one-year survival after mitral TEER, guiding better clinical decisions and outcomes.

Achieving Low Disease Activity in Lupus Reduces Organ Damage and Flare Risk

New research highlights that achieving low disease activity or remission in lupus patients significantly reduces organ damage and flare risks.

Handshake on a green background

Lilly gains EU backing for drug to treat Crohn’s disease

The drug has received a nod from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Metabolic Imaging Distinguishes Ovarian Cancer Subtypes

Hyperpolarised 13C magnetic resonance spectroscopy can clinically distinguish between ovarian tumour subtypes.